Literature DB >> 11588598

Expression of hMTH1 in the hippocampi of control and Alzheimer's disease.

A Furuta1, T Iida, Y Nakabeppu, T Iwaki.   

Abstract

The oxidized purine nucleoside triphosphatase, hMTH1, has a critical role towards preventing errors caused by oxidized purine nucleoside triphosphates such as 8-oxo-dGTP and 2-hydroxy-dATP. We investigated the immunohistochemical expression of hMTH1 in human hippocampal postmortem tissues representing non-neurological disease and Alzheimer's disease (AD). In the non-neurological subjects the hMTH1 protein was enriched in the stratum lucidum at CA3 corresponding to mossy fiber synapses. In AD subjects, the synaptic immunoreactivities at CA3 were significantly decreased, whereas they tended to be increased at the entorhinal cortex. We suggest that the expression of hMTH1 indicates indirect evidence of oxidative stress and its regulation is regionally differentiated in AD.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11588598     DOI: 10.1097/00001756-200109170-00028

Source DB:  PubMed          Journal:  Neuroreport        ISSN: 0959-4965            Impact factor:   1.837


  13 in total

Review 1.  Oxidative damage to RNA in aging and neurodegenerative disorders.

Authors:  Akihiko Nunomura; Paula I Moreira; Rudy J Castellani; Hyoung-Gon Lee; Xiongwei Zhu; Mark A Smith; George Perry
Journal:  Neurotox Res       Date:  2012-06-06       Impact factor: 3.911

2.  8-Oxoguanine causes neurodegeneration during MUTYH-mediated DNA base excision repair.

Authors:  Zijing Sheng; Sugako Oka; Daisuke Tsuchimoto; Nona Abolhassani; Hiroko Nomaru; Kunihiko Sakumi; Hidetaka Yamada; Yusaku Nakabeppu
Journal:  J Clin Invest       Date:  2012-11-12       Impact factor: 14.808

3.  The GT to GC single nucleotide polymorphism at the beginning of an alternative exon 2C of human MTH1 gene confers an amino terminal extension that functions as a mitochondrial targeting signal.

Authors:  Yasunari Sakai; Hisanobu Oda; Daisuke Yoshimura; Masato Furuichi; Dongchon Kang; Shigenori Iwai; Toshiro Hara; Yusaku Nakabeppu
Journal:  J Mol Med (Berl)       Date:  2006-04-11       Impact factor: 4.599

4.  Translocation of glutamate transporter subtype excitatory amino acid carrier 1 protein in kainic acid-induced rat epilepsy.

Authors:  Akiko Furuta; Mami Noda; Satoshi O Suzuki; Yoshinobu Goto; Yoshiko Kanahori; Jeffrey D Rothstein; Toru Iwaki
Journal:  Am J Pathol       Date:  2003-08       Impact factor: 4.307

5.  MTH1, an oxidized purine nucleoside triphosphatase, suppresses the accumulation of oxidative damage of nucleic acids in the hippocampal microglia during kainate-induced excitotoxicity.

Authors:  Kosuke Kajitani; Hiroo Yamaguchi; Yukihiko Dan; Masato Furuichi; Dongchon Kang; Yusaku Nakabeppu
Journal:  J Neurosci       Date:  2006-02-08       Impact factor: 6.167

Review 6.  The role of DNA repair in brain related disease pathology.

Authors:  Chandrika Canugovi; Magdalena Misiak; Leslie K Ferrarelli; Deborah L Croteau; Vilhelm A Bohr
Journal:  DNA Repair (Amst)       Date:  2013-05-27

7.  Sublethal RNA oxidation as a mechanism for neurodegenerative disease.

Authors:  Rudy J Castellani; Akihiko Nunomura; Raj K Rolston; Paula I Moreira; Atsushi Takeda; George Perry; Mark A Smith
Journal:  Int J Mol Sci       Date:  2008-05-20       Impact factor: 6.208

Review 8.  Oxidative DNA damage in mild cognitive impairment and late-stage Alzheimer's disease.

Authors:  Mark A Lovell; William R Markesbery
Journal:  Nucleic Acids Res       Date:  2007-10-18       Impact factor: 16.971

Review 9.  The Response to Oxidative DNA Damage in Neurons: Mechanisms and Disease.

Authors:  Laura Narciso; Eleonora Parlanti; Mauro Racaniello; Valeria Simonelli; Alessio Cardinale; Daniela Merlo; Eugenia Dogliotti
Journal:  Neural Plast       Date:  2016-01-31       Impact factor: 3.599

Review 10.  The impact of base excision DNA repair in age-related neurodegenerative diseases.

Authors:  Giovana S Leandro; Peter Sykora; Vilhelm A Bohr
Journal:  Mutat Res       Date:  2015-01-04       Impact factor: 2.433

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.